Effect of rebamipide in soft contact lens patients with dry eyes.
Not Applicable
- Conditions
- dry eye
- Registration Number
- JPRN-UMIN000019738
- Lead Sponsor
- ippon Medical School Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patient with drug allergy. Patient with allergic conjunctivitis or allergic rhinitis. Patient with more than 2 points for examination of corneal fluorescein staining score.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does rebamipide modulate to improve tear film stability in contact lens-induced dry eye?
How does rebamipide compare to cyclosporine A in treating evaporative dry eye among soft contact lens users?
Are specific biomarkers like tear osmolarity or matrix metalloproteinase-9 predictive of rebamipide response in contact lens-related dry eye?
What adverse events are associated with rebamipide use in contact lens patients, and how are they managed clinically?
What combination therapies with rebamipide show promise for managing meibomian gland dysfunction in contact lens wearers with dry eye?